HomeHealthcareMedical Devices Radiosurgery Market

Radiosurgery Market Size, Share & Trends Analysis Report By Technology (Cobalt 60 Systems (Gamma Knife), Electron Emitting High-Energy Linear Accelerator (Linac), Proton Beam Therapy), By End-User (Hospitals, Clinics, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 05, 2026 | Author: Dhanashri Chandgude | Format:

Radiosurgery Market Size & Growth Analysis 

The global radiosurgery market size was valued at USD 2.62 billion in 2025 and is projected to grow from USD 2.79 billion in 2026 to USD 4.58 billion by 2034, registering a CAGR of 6.4% during the forecast period (2026–2034). North America dominated the radiosurgery market with a share of 39.8% in 2025.

Radiosurgery is a non-invasive medical procedure that uses precisely targeted radiation to treat tumors and other abnormalities in the body. Unlike traditional surgery, radiosurgery does not involve making incisions. Instead, it delivers highly focused radiation beams to the affected area, destroying abnormal tissue while minimizing damage to surrounding healthy tissue. This technique is commonly used to treat brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgia, and other conditions.

Radiosurgery Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 2.62 Billion
2026 Market Size
USD 2.79 Billion
2034 Projected Market Size
USD 4.58 Billion
Forecast Period
2026–2034
Base Year
2025
Market CAGR (2026–2034)
6.4%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
39.8%
Fastest-growing Region
Europe
Europe CAGR (2026–2034)
6.6%

Segment Insights

By Technology
Leading Segment
Electron Emitting High-Energy Linear Accelerator (Linac)
Market Share in 2025 48.7%
By End User
Fastest-growing Segment
Hospitals
CAGR 6% (2026–2034)
Radiosurgery Market Size , Share and Growth Forecast 2026-2034

Download a Free SampleTo learn more about this report.

Radiosurgery Market Dynamics

01

Cancer Disease Burden Drive Market

The rising incidence of cancer across different organ systems is increasing the need for effective and targeted treatment options, including radiosurgery. Healthcare providers use radiosurgery to treat selected tumors in the brain, lungs, liver, spine, and other anatomical sites by delivering concentrated radiation to abnormal tissues while limiting exposure to surrounding healthy structures. The clinical application of radiosurgery across multiple tumor types supports its adoption in specialized oncology centers and hospitals.

02

Preference for Minimally Invasive Cancer Treatments Increase Market Demand

The preference for treatment approaches that avoid conventional surgery is supporting the adoption of radiosurgery among eligible cancer patients. Radiosurgery delivers focused radiation without surgical incisions, helping reduce procedure-related complications and the need for extended hospitalization in appropriate cases. Its ability to provide targeted treatment with shorter recovery requirements encourages healthcare providers to include radiosurgery in treatment plans for selected tumors and neurological conditions.

03

Impact Analysis of Key Drivers in Radiosurgery Market

DriversMarket Impact

Increasing Cancer Disease Burden

The need for effective treatment options for brain, lung, liver, and other tumors increases the use of radiosurgery as a non-invasive treatment approach.

Preference for Minimally Invasive Cancer Treatments

Patients and healthcare providers favor non-invasive treatment options that reduce surgical complications, hospital stays, and recovery time, supporting radiosurgery adoption.

Expansion of Specialized Cancer Treatment Centers

The establishment of dedicated oncology hospitals and radiation therapy centers increases access to radiosurgery equipment and specialized treatment services.

Demand for Outpatient Cancer Treatment

Radiosurgery enables selected patients to receive precise radiation treatment without conventional surgical procedures or extended hospitalization, supporting its use in outpatient care settings.

Improved Access to Oncology Care

Investments in cancer care infrastructure, radiation therapy facilities, and specialized medical services improve access to radiosurgery across established and emerging healthcare systems.

01

High Equipment Installation and Maintenance Costs Limit Healthcare Facility Adoption

Radiosurgery systems require substantial investments in advanced imaging technologies, precision treatment equipment, specialized facilities, and supporting infrastructure. Regular maintenance, software upgrades, and equipment calibration further increase the financial burden on healthcare providers. These high costs can discourage smaller hospitals and treatment centers from installing radiosurgery systems, limiting treatment availability and wider adoption.

02

Shortage of Skilled Medical Professionals Restricts Treatment Availability

Radiosurgery procedures require specialized expertise from neurosurgeons, radiation oncologists, medical physicists, and trained technical personnel to ensure accurate treatment planning and delivery. The limited availability of these professionals, particularly in developing and underserved regions, can restrict the number of facilities capable of providing radiosurgery services. This workforce shortage can delay treatment access and slow the expansion of radiosurgery services.

03

Impact Analysis of Key Restraints in Radiosurgery Market

RestraintsMarket Impact

High Equipment Installation and Maintenance Costs

Advanced radiosurgery systems require substantial capital investment, specialized facilities, and regular maintenance, limiting adoption among smaller hospitals and healthcare centers.

Shortage of Skilled Medical Professionals

Radiosurgery requires trained neurosurgeons, radiation oncologists, medical physicists, and technical specialists, restricting treatment availability in regions with limited expertise.

Risk of Radiation Exposure and Treatment-Related Complications

Concerns about radiation damage to surrounding healthy tissues and potential treatment complications can affect patient acceptance and clinical suitability.

Limited Accessibility in Developing and Remote Regions

Inadequate healthcare infrastructure, limited specialized treatment centers, and high treatment expenses restrict access to radiosurgery services.

Stringent Regulatory and Clinical Safety Requirements

Strict equipment approval, radiation safety, and clinical validation requirements increase compliance expenses and can delay the adoption of advanced radiosurgery technologies.

01

Radiosurgery-Immunotherapy Integration

Oncology hospitals, cancer centers, radiation specialists, and pharmaceutical companies can combine radiosurgery with immunotherapy for selected cancer treatment pathways. Combination protocols create revenue opportunities through treatment packages, clinical collaborations, and demand for advanced radiation systems. Companies such as Varian and Elekta operate in advanced radiation oncology technologies.

02

Expansion of Outpatient Services

Hospitals, ambulatory treatment centers, and radiation oncology providers can deliver selected radiosurgery procedures without prolonged inpatient stays. Outpatient models create revenue through higher treatment throughput, facility utilization, procedure-based payments, and related patient services.

Radiosurgery Market Segmentation Analysis

By Technology

The electron emitting high-energy linear accelerator (linac) accounted for a share of 48.7% in 2025, supported by its widespread use in radiation therapy and its ability to deliver precise, high-energy radiation for cancer treatment.

The cobalt 60 systems (gamma knife) are projected to register a CAGR of 5.4% during the forecast period, driven by their application in stereotactic radiosurgery and their ability to deliver targeted radiation treatment for selected neurological conditions.

Radiosurgery Market Size By Segments

Request Customizationto receive a tailored report.

By End User

Hospitals accounted for a share of 68.9% in 2025, owing to their advanced radiotherapy infrastructure, access to specialized oncology teams, and capacity to manage complex cancer treatment procedures.

The clinics are projected to register a CAGR of 5.8% during the forecast period, supported by the availability of specialized outpatient treatment services and increasing access to focused cancer care.

Radiosurgery Market Share By Segments

Speak to an Analystto discuss market opportunities.

Radiosurgery Market Regional Outlook

North America Radiosurgery Market

North America radiosurgery market accounted for a dominant share of 39.8% in 2025.

U.S. Radiosurgery Market

The U.S. radiosurgery sector benefits from established cancer care infrastructure and the availability of advanced stereotactic treatment systems. Hospitals and specialized oncology centres use technologies such as Gamma Knife and CyberKnife for the treatment of selected brain, spinal, and extracranial tumors. Clinical demand for precise radiation delivery and reduced treatment sessions supports technology adoption.

Canada Radiosurgery Market

Canada’s radiosurgery landscape is supported by specialized cancer centres and investments in advanced radiation oncology infrastructure. Hospitals use stereotactic radiosurgery and stereotactic body radiation therapy for selected neurological and oncological conditions. Demand for precise treatment delivery and access to specialized cancer care supports the use of radiosurgery systems.

North America Radiosurgery Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Radiosurgery Market

Europe radiosurgery market is projected to register a CAGR of 6.6% during the forecast period, making it the fastest-growing market.

U.K. Radiosurgery Market

The U.K. radiosurgery sector is supported by specialized cancer treatment centres and the National Health Service's investment in advanced radiotherapy services. Stereotactic radiosurgery is used for selected brain tumors and other neurological conditions, while stereotactic body radiation therapy supports treatment of certain extracranial tumors. Clinical emphasis on precise radiation delivery and treatment planning supports demand for advanced systems.

Germany Radiosurgery Market

Germany’s radiosurgery industry benefits from advanced hospital infrastructure, specialized oncology facilities, and access to precision radiation technologies. Hospitals and cancer centres use stereotactic treatment systems for selected brain, spinal, and extracranial tumors. Established medical technology capabilities and clinical demand for minimally invasive treatment approaches support the adoption of radiosurgery equipment.

Asia Pacific Radiosurgery Market

The Asia Pacific radiosurgery market is projected to register a CAGR of 6.3% during the forecast period.

China Radiosurgery Market

China’s radiosurgery sector benefits from investments in advanced cancer treatment facilities and the expansion of specialized radiotherapy services. Hospitals use stereotactic treatment technologies for selected brain and extracranial tumors, while improvements in imaging and treatment planning support precision radiation delivery. The expansion of oncology infrastructure also creates opportunities for equipment suppliers and specialized service providers.

India Radiosurgery Market

India’s radiosurgery sector is supported by the expansion of private and public cancer care facilities and increasing access to advanced radiation oncology technologies. Specialized hospitals use stereotactic radiosurgery and stereotactic body radiation therapy for selected neurological and cancer conditions. Investments in oncology infrastructure and demand for precise treatment options support the adoption of advanced radiosurgery systems.

Japan Radiosurgery Market

Japan’s radiosurgery landscape benefits from advanced medical technology infrastructure and established cancer treatment services. Hospitals use stereotactic radiosurgery for selected intracranial conditions and stereotactic radiation techniques for certain extracranial tumors. The country’s emphasis on precision treatment and advanced imaging supports the use of sophisticated radiosurgery platforms.

Competitive Landscape

The radiosurgery market is moderately consolidated, with competition involving medical technology manufacturers, radiation therapy equipment providers, specialized oncology technology companies, and healthcare equipment suppliers. The leading players in the market include Varian Medical Systems, Elekta, and Accuray, accounting for 35–40% of the global radiosurgery market share.

Established players compete primarily on treatment precision, equipment reliability, clinical performance, imaging integration, treatment planning capabilities, regulatory compliance, and global service networks. Emerging and specialized players in the radiosurgery market ecosystem compete through advanced radiation delivery technologies, improved patient positioning systems, AI-enabled treatment planning, compact equipment designs, cost-effective solutions, and innovations that enhance treatment accuracy and workflow efficiency.

List of Key and Emerging Players in Radiosurgery Market

Siemens AG (Germany) Varian Medical Systems, Inc. (U.S.) Elekta AB (Sweden)
Accuray Incorporated (U.S.)
Ion Beam Applications SA (Belgium)
C. R. Bard, Inc. (U.S.)
Mevion Medical Systems, Inc. (U.S.)
Nordion (Canada)
NTP Radioisotopes SOC Ltd. (South Africa)
Mallinckrodt plc (Ireland)

Key Industry Developments

May 2026
Accuray Incorporated and the University of Wisconsin School of Medicine and Public Health announced a 10-year strategic research collaboration to advance personalized cancer treatment using Accuray’s adaptive radiation therapy technologies. The collaboration focuses on clinical research, education, training, and development of adaptive treatment approaches that support precision radiation therapy applications.
January 2026
Elekta received U.S. FDA 510(k) clearance for its Elekta Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy. The regulatory approval expanded the clinical applications of Elekta’s stereotactic radiosurgery platform beyond traditional intracranial tumor treatments.
September 2025
Accuray launched the Accuray Stellar™ Solution, an advanced radiotherapy solution based on the Radixact® Treatment Delivery System. The platform introduced adaptive radiotherapy capabilities designed to provide clinicians with enhanced treatment flexibility and precision for individualized cancer care.
September 2025
Elekta announced that its Leksell Gamma Knife radiosurgery platform reached the milestone of treating more than two million patients globally. The milestone highlighted the continued clinical adoption of Gamma Knife technology in stereotactic radiosurgery applications.

Report Scope

Segmentation

By Technology 3
  • Cobalt 60 Systems (Gamma Knife)
  • Electron Emitting High-Energy Linear Accelerator (Linac)
  • Proton Beam Therapy
By End-User 3
  • Hospitals
  • Clinics
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Siemens AG (Germany) · Varian Medical Systems, Inc. (U.S.) · Elekta AB (Sweden) · Accuray Incorporated (U.S.) · Ion Beam Applications SA (Belgium)
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Reportto Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The radiosurgery market size is valued at USD 2.79 Billion in 2026 and is projected to reach USD 4.58 Billion by 2034, at a CAGR of 6.4% during the forecast period 2026-2034.
North America dominated the market with a share of 39.8% in 2025.
The leading players in this market are Siemens, Varian Medical Systems, Elekta AB, Accuray Incorporated, Ion Beam Applications SA.
The radiosurgery market is projected to grow at a CAGR of 6.4% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG ElectronicsAMCAD EngineeringKOBE STEEL LTD.Hindustan National Glass & Industries LimitedVoith GroupInternational PaperHansol PaperWhirlpool CorporationSonySamsung ElectronicsQualcommGoogleFiservVeto-PharmaNippon Becton DickinsonMerckArgon Medical DevicesAbbottAjinomotoDenonDoosanMeiji Seika Kaisha LtdLG ChemicalsLCY chemical groupBayerAirraneBASFToyota IndustriesNissan MotorsNeenahMitsubishiHyundai Motor CompanyHondaCRP Industries IncpewagLGEPanasonicLubrizol CorporationLeonardoJohnson & JohnsonHB FullerMITSUBISHI CHEMICALHyundai MobisAmazon
Request SampleOrder Report Now